Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emrosi (DFD-29) in papulopustular rosacea
NCT05296629Phase 3Completed
- Sponsor
- Journey Medical Corporation
- Start
- Mar 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in papulopustular rosacea, sponsored by Journey Medical Corporation. Started Mar 2022; status: completed.
02
Drugs
minocycline
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT05296629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05296629.